Cognition Therapeutics Statistics Share Statistics Cognition Therapeutics has 73.47M
shares outstanding. The number of shares has increased by 54.47%
in one year.
Shares Outstanding 73.47M Shares Change (YoY) 54.47% Shares Change (QoQ) 0.03% Owned by Institutions (%) 18.81% Shares Floating 59.05M Failed to Deliver (FTD) Shares 32,576 FTD / Avg. Volume 0.3%
Short Selling Information The latest short interest is 6.23M, so 8.48% of the outstanding
shares have been sold short.
Short Interest 6.23M Short % of Shares Out 8.48% Short % of Float 9.27% Short Ratio (days to cover) 1
Valuation Ratios The PE ratio is -0.82 and the forward
PE ratio is -9.25.
Cognition Therapeutics's PEG ratio is
0.71.
PE Ratio -0.82 Forward PE -9.25 PS Ratio 0 Forward PS 10.7 PB Ratio 1.49 P/FCF Ratio -0.98 PEG Ratio 0.71
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Cognition Therapeutics.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 2.65,
with a Debt / Equity ratio of 0.04.
Current Ratio 2.65 Quick Ratio 2.65 Debt / Equity 0.04 Debt / EBITDA -0.02 Debt / FCF -0.03 Interest Coverage -2158.64
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee n/a Profits Per Employee $-1.36M Employee Count 25 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by 358.06% in the
last 52 weeks. The beta is 1.33, so Cognition Therapeutics's
price volatility has been higher than the market average.
Beta 1.33 52-Week Price Change 358.06% 50-Day Moving Average 1.19 200-Day Moving Average 0.65 Relative Strength Index (RSI) 65.84 Average Volume (20 Days) 10,859,332
Income Statement
Revenue n/a Gross Profit -266K Operating Income -53.97M Net Income -33.97M EBITDA -33.68M EBIT -33.95M Earnings Per Share (EPS) -0.85
Full Income Statement Balance Sheet The company has 25.01M in cash and 814K in
debt, giving a net cash position of 24.2M.
Cash & Cash Equivalents 25.01M Total Debt 814K Net Cash 24.2M Retained Earnings -175.16M Total Assets 19.62M Working Capital 6.68M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -28.47M
and capital expenditures -4K, giving a free cash flow of -28.48M.
Operating Cash Flow -28.47M Capital Expenditures -4K Free Cash Flow -28.48M FCF Per Share -0.72
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
